Annual Net Income
-$19.38 M
-$5.71 M-41.72%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual net profit is -$19.38 million, with the most recent change of -$5.71 million (-41.72%) on December 31, 2023.
- During the last 3 years, DMAC annual net income has fallen by -$7.09 million (-57.67%).
- DMAC annual net income is now -9102.75% below its all-time high of -$210.60 thousand, reached on December 31, 2005.
Performance
DMAC Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$6.27 M
-$1.16 M-22.56%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly net profit is -$6.27 million, with the most recent change of -$1.16 million (-22.56%) on September 30, 2024.
- Over the past year, DMAC quarterly net income has dropped by -$1.80 million (-40.33%).
- DMAC quarterly net income is now -62018.81% below its all-time high of -$10.10 thousand, reached on June 1, 2003.
Performance
DMAC Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$21.70 M
-$1.80 M-9.06%
September 30, 2024
Summary
- As of February 7, 2025, DMAC TTM net profit is -$21.70 million, with the most recent change of -$1.80 million (-9.06%) on September 30, 2024.
- Over the past year, DMAC TTM net income has dropped by -$3.73 million (-20.78%).
- DMAC TTM net income is now -214800.99% below its all-time high of -$10.10 thousand, reached on June 1, 2003.
Performance
DMAC TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
DMAC Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.7% | -40.3% | -20.8% |
| 3 y3 years | -57.7% | -81.9% | -49.2% |
| 5 y5 years | -238.0% | -81.9% | -49.2% |
DMAC Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.6% | at low | -105.1% | at low | -64.8% | at low |
| 5 y | 5-year | -82.0% | at low | -158.7% | at low | -121.0% | at low |
| alltime | all time | -9102.8% | at low | <-9999.0% | at low | <-9999.0% | at low |
DiaMedica Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.27 M(+22.6%) | -$21.70 M(+9.1%) |
| Jun 2024 | - | -$5.12 M(-0.6%) | -$19.90 M(+3.3%) |
| Mar 2024 | - | -$5.15 M(-0.2%) | -$19.26 M(-0.6%) |
| Dec 2023 | -$19.38 M(+41.7%) | -$5.16 M(+15.4%) | -$19.38 M(+7.8%) |
| Sep 2023 | - | -$4.47 M(-0.1%) | -$17.97 M(+8.5%) |
| Jun 2023 | - | -$4.48 M(-15.1%) | -$16.56 M(+7.2%) |
| Mar 2023 | - | -$5.27 M(+40.5%) | -$15.44 M(+12.9%) |
| Dec 2022 | -$13.68 M(+0.6%) | -$3.75 M(+22.6%) | -$13.68 M(+3.8%) |
| Sep 2022 | - | -$3.06 M(-8.9%) | -$13.17 M(-2.9%) |
| Jun 2022 | - | -$3.36 M(-4.3%) | -$13.56 M(+0.6%) |
| Mar 2022 | - | -$3.51 M(+8.1%) | -$13.48 M(-0.8%) |
| Dec 2021 | -$13.59 M(+10.6%) | -$3.25 M(-5.9%) | -$13.59 M(-6.6%) |
| Sep 2021 | - | -$3.45 M(+5.4%) | -$14.55 M(+1.8%) |
| Jun 2021 | - | -$3.27 M(-9.6%) | -$14.29 M(+5.9%) |
| Mar 2021 | - | -$3.62 M(-13.8%) | -$13.49 M(+9.7%) |
| Dec 2020 | -$12.29 M(+15.4%) | -$4.20 M(+31.5%) | -$12.29 M(+16.3%) |
| Sep 2020 | - | -$3.19 M(+29.1%) | -$10.57 M(+7.6%) |
| Jun 2020 | - | -$2.47 M(+2.0%) | -$9.83 M(+0.1%) |
| Mar 2020 | - | -$2.42 M(-2.2%) | -$9.82 M(-7.8%) |
| Dec 2019 | -$10.65 M(+85.7%) | -$2.48 M(+1.3%) | -$10.65 M(+5.1%) |
| Sep 2019 | - | -$2.45 M(-0.9%) | -$10.13 M(+11.7%) |
| Jun 2019 | - | -$2.47 M(-24.1%) | -$9.07 M(+8.8%) |
| Mar 2019 | - | -$3.25 M(+65.7%) | -$8.34 M(+45.4%) |
| Dec 2018 | -$5.73 M(+34.6%) | -$1.96 M(+41.5%) | -$5.73 M(+20.6%) |
| Sep 2018 | - | -$1.39 M(-20.1%) | -$4.76 M(+11.5%) |
| Jun 2018 | - | -$1.74 M(+166.9%) | -$4.26 M(+18.4%) |
| Mar 2018 | - | -$650.00 K(-33.9%) | -$3.60 M(-15.5%) |
| Dec 2017 | -$4.26 M(+91.9%) | -$983.60 K(+9.8%) | -$4.26 M(+14.7%) |
| Sep 2017 | - | -$896.10 K(-16.4%) | -$3.72 M(-1.1%) |
| Jun 2017 | - | -$1.07 M(-18.1%) | -$3.76 M(+17.5%) |
| Mar 2017 | - | -$1.31 M(+198.4%) | -$3.20 M(+44.0%) |
| Dec 2016 | -$2.22 M(+39.3%) | -$438.70 K(-53.1%) | -$2.22 M(-7.9%) |
| Sep 2016 | - | -$936.30 K(+82.4%) | -$2.41 M(+41.0%) |
| Jun 2016 | - | -$513.30 K(+54.7%) | -$1.71 M(+11.6%) |
| Mar 2016 | - | -$331.70 K(-47.3%) | -$1.53 M(-6.8%) |
| Dec 2015 | -$1.59 M(-66.9%) | -$630.00 K(+168.2%) | -$1.64 M(-6.9%) |
| Sep 2015 | - | -$234.90 K(-30.0%) | -$1.76 M(-26.8%) |
| Jun 2015 | - | -$335.50 K(-24.3%) | -$2.41 M(-27.0%) |
| Mar 2015 | - | -$443.40 K(-41.0%) | -$3.30 M(-32.5%) |
| Dec 2014 | -$4.82 M(-35.0%) | -$751.20 K(-14.8%) | -$4.89 M(-8.4%) |
| Sep 2014 | - | -$881.60 K(-28.1%) | -$5.34 M(-7.5%) |
| Jun 2014 | - | -$1.23 M(-39.7%) | -$5.77 M(-14.0%) |
| Mar 2014 | - | -$2.03 M(+69.6%) | -$6.71 M(-9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$7.41 M(-26.3%) | -$1.20 M(-8.9%) | -$7.40 M(-19.4%) |
| Sep 2013 | - | -$1.32 M(-39.2%) | -$9.19 M(-12.1%) |
| Jun 2013 | - | -$2.16 M(-20.6%) | -$10.45 M(-3.6%) |
| Mar 2013 | - | -$2.73 M(-8.6%) | -$10.84 M(+9.0%) |
| Dec 2012 | -$10.05 M(+52.1%) | -$2.98 M(+15.6%) | -$9.94 M(+12.0%) |
| Sep 2012 | - | -$2.58 M(+1.0%) | -$8.88 M(+10.1%) |
| Jun 2012 | - | -$2.55 M(+39.4%) | -$8.06 M(+14.7%) |
| Mar 2012 | - | -$1.83 M(-4.6%) | -$7.03 M(+3.1%) |
| Dec 2011 | -$6.61 M(+55.5%) | -$1.92 M(+8.9%) | -$6.81 M(+0.6%) |
| Sep 2011 | - | -$1.76 M(+16.1%) | -$6.77 M(+12.3%) |
| Jun 2011 | - | -$1.52 M(-6.2%) | -$6.03 M(+11.9%) |
| Mar 2011 | - | -$1.62 M(-13.9%) | -$5.39 M(+27.3%) |
| Dec 2010 | -$4.25 M(+74.5%) | -$1.88 M(+84.1%) | -$4.24 M(+44.7%) |
| Sep 2010 | - | -$1.02 M(+16.3%) | -$2.93 M(+16.7%) |
| Jun 2010 | - | -$876.60 K(+90.0%) | -$2.51 M(+19.7%) |
| Mar 2010 | - | -$461.40 K(-18.9%) | -$2.10 M(-8.0%) |
| Dec 2009 | -$2.44 M(+31.4%) | -$569.20 K(-5.4%) | -$2.28 M(+11.5%) |
| Sep 2009 | - | -$601.90 K(+30.0%) | -$2.04 M(-5.2%) |
| Jun 2009 | - | -$463.10 K(-28.1%) | -$2.16 M(-7.8%) |
| Mar 2009 | - | -$644.50 K(+93.0%) | -$2.34 M(+24.1%) |
| Dec 2008 | -$1.85 M(-20.6%) | -$334.00 K(-53.2%) | -$1.88 M(-13.9%) |
| Sep 2008 | - | -$714.10 K(+10.8%) | -$2.19 M(+15.8%) |
| Jun 2008 | - | -$644.60 K(+237.7%) | -$1.89 M(-16.3%) |
| Mar 2008 | - | -$190.90 K(-70.1%) | -$2.26 M(+1.1%) |
| Dec 2007 | -$2.33 M(+199.9%) | -$637.40 K(+53.2%) | -$2.23 M(+23.6%) |
| Sep 2007 | - | -$416.10 K(-58.9%) | -$1.81 M(+10.7%) |
| Jun 2007 | - | -$1.01 M(+507.4%) | -$1.63 M(+100.1%) |
| Mar 2007 | - | -$166.80 K(-20.8%) | -$815.70 K(-2.5%) |
| Dec 2006 | -$778.00 K(+269.4%) | -$210.60 K(-13.0%) | -$836.50 K(+23.3%) |
| Sep 2006 | - | -$242.00 K(+23.3%) | -$678.70 K(+38.7%) |
| Jun 2006 | - | -$196.30 K(+4.6%) | -$489.30 K(+42.7%) |
| Mar 2006 | - | -$187.60 K(+255.3%) | -$342.90 K(+66.6%) |
| Dec 2005 | -$210.60 K(-67.1%) | -$52.80 K(+0.4%) | -$205.80 K(-41.8%) |
| Sep 2005 | - | -$52.60 K(+5.4%) | -$353.70 K(+11.8%) |
| Jun 2005 | - | -$49.90 K(-1.2%) | -$316.50 K(-3.1%) |
| Mar 2005 | - | -$50.50 K(-74.8%) | -$326.70 K(+13.2%) |
| Dec 2004 | -$640.00 K | - | - |
| Dec 2004 | - | -$200.70 K(+1203.2%) | -$288.50 K(+75.2%) |
| Sep 2004 | - | -$15.40 K(-74.4%) | -$164.70 K(-2.5%) |
| Jun 2004 | - | -$60.10 K(+388.6%) | -$168.90 K(+42.1%) |
| Mar 2004 | - | -$12.30 K(-84.0%) | -$118.90 K(+11.5%) |
| Dec 2003 | - | -$76.90 K(+292.3%) | -$106.60 K(+258.9%) |
| Sep 2003 | - | -$19.60 K(+94.1%) | -$29.70 K(+194.1%) |
| Jun 2003 | - | -$10.10 K | -$10.10 K |
FAQ
- What is DiaMedica Therapeutics annual net profit?
- What is the all time high annual net income for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual net income year-on-year change?
- What is DiaMedica Therapeutics quarterly net profit?
- What is the all time high quarterly net income for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly net income year-on-year change?
- What is DiaMedica Therapeutics TTM net profit?
- What is the all time high TTM net income for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics TTM net income year-on-year change?
What is DiaMedica Therapeutics annual net profit?
The current annual net income of DMAC is -$19.38 M
What is the all time high annual net income for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual net profit is -$210.60 K
What is DiaMedica Therapeutics annual net income year-on-year change?
Over the past year, DMAC annual net profit has changed by -$5.71 M (-41.72%)
What is DiaMedica Therapeutics quarterly net profit?
The current quarterly net income of DMAC is -$6.27 M
What is the all time high quarterly net income for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly net profit is -$10.10 K
What is DiaMedica Therapeutics quarterly net income year-on-year change?
Over the past year, DMAC quarterly net profit has changed by -$1.80 M (-40.33%)
What is DiaMedica Therapeutics TTM net profit?
The current TTM net income of DMAC is -$21.70 M
What is the all time high TTM net income for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high TTM net profit is -$10.10 K
What is DiaMedica Therapeutics TTM net income year-on-year change?
Over the past year, DMAC TTM net profit has changed by -$3.73 M (-20.78%)